Ocugen Inc

General ticker "OCGN" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $253.8M

Ocugen Inc follows the US Stock Market performance with the rate: 18.7%.

Estimated limits based on current volatility of 4.2%: low 0.74$, high 0.81$

Factors to consider:

  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [0.25$, 0.87$]
  • 2024-12-30 to 2025-12-30 estimated range: [0.37$, 1.12$]

Financial Metrics affecting the OCGN estimates:

  • Negative: Non-GAAP EPS, $ of -0.33 <= 0.10
  • Negative: Operating profit margin, % of -91.57 <= 1.03
  • Negative: Operating cash flow per share per price, % of -39.20 <= 2.35
  • Positive: Interest expense per share, $ of 0 <= 0
  • Positive: Industry inventory ratio change (median), % of 0 <= 0
  • Negative: negative Net income

Similar symbols

Short-term OCGN quotes

Long-term OCGN plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $0.00MM $0.00MM $6.04MM
Operating Expenses $58.03MM $84.87MM $71.57MM
Operating Income $-58.03MM $-84.87MM $-65.53MM
Non-Operating Income $-0.39MM $3.52MM $2.45MM
Interest Expense $0.08MM $0.00MM $0.00MM
R&D Expense $35.11MM $49.76MM $39.57MM
Income(Loss) $-58.42MM $-81.35MM $-63.08MM
Taxes $-0.05MM $0.00MM $0.00MM
Profit(Loss) $-58.37MM $-81.35MM $-63.08MM
Stockholders Equity $95.82MM $84.05MM $40.56MM
Assets $105.76MM $108.63MM $64.55MM
Operating Cash Flow $-47.94MM $-60.08MM $-62.05MM
Capital expenditure $0.94MM $4.46MM $10.48MM
Investing Cash Flow $-1.82MM $-16.97MM $3.08MM
Financing Cash Flow $120.68MM $59.48MM $20.88MM
Earnings Per Share* $-0.30 $-0.36 $-0.26

* EPS are Split Adjusted, recent splits may be reflected with a delay.